Sign Up

Understanding Cancer: The Biology of Risk, Resilience & Repair

Reserve Your Spot for This Groundbreaking Presentation

Exclusive for Live Attendees

:gift: Live-Attendee Giveaway!Join us live for a chance to win a complimentary ProdromeScan with a personal interpretation by Dr. Dayan Goodenowe! One lucky winner will be notified by email. For research and educational purposes only. Not for diagnostic use. (US RESIDENTS ONLY)

Join Dr. Dayan Goodenowe for a comprehensive discussion about the biochemical foundations of cancer—how it develops within our own cells and what emerging research reveals about cellular stress, resilience, and adaptive responses.

Everybody Has a Story About Cancer

Someone you love has probably had cancer—one of your parents, one of your grandparents, one of your siblings.

But it can be a very wide variety of cancers: pancreatic cancer, ovarian cancer, breast cancer, colon cancer.

How can we possibly have so many different cancers in the human body?

The First Step Forward is Understanding the Science

In 2025, an estimated 2,041,910 new cancer cases will be diagnosed in the United States. That’s 5,600 people every single day.

And despite the vast array of cancer types – breast, prostate, lung, colon, and hundreds more – all cancers share fundamental biochemical phenotypes that transcend tissue type and location.

That’s because cancer isn’t a genetic lottery. It’s a biochemical process that develops within your own cells when specific metabolic pathways become disrupted.

In 2025, an estimated 2,041,910 new cancer cases will be diagnosed in the United States. That’s 5,600 people every single day.

That’s because cancer isn’t a genetic lottery. It’s a biochemical process that develops within your own cells when specific metabolic pathways become disrupted.

Tuesday, November 19th, 2025 • 4:00 PM Pacific

What Really Happens When Cancer Develops

Research from The Cancer Genome Atlas shows 89% of all tumors share alterations in the same core biochemical pathways regardless of cancer type.

These shared mechanisms include:

Consider this: Cancer mortality has declined 34% since 1991, averting 4.5 million deaths. Yet incidences continue rising, especially in women and younger adults.

The challenge: conventional approaches focus on attacking cancer after it forms rather than addressing the underlying biochemical factors that allow it to develop. From 2012 to 2021, cancer incidence increased 2.4% per year in adults under 50.

Why? 

Because we’re not addressing the root biochemical causes: the cellular stress and metabolic disruptions that create conditions favorable for cancer development. 

The Hidden Biochemical Truth About Cancer

All cancers, whether pancreatic, breast, colon, or lung, are fundamentally diseases of cellular metabolism and stress response.

Research shows metabolic reprogramming is common across virtually all tumor types. Cancer cells alter their energy production, lipid synthesis, and amino acid metabolism in remarkably similar ways, regardless of tissue origin.

How can cancers in completely different organs share such striking similarities?

Because they exploit the same underlying biochemical vulnerabilities in cellular function.

Research shows metabolic reprogramming is common across virtually all tumor types. Cancer cells alter their energy production, lipid synthesis, and amino acid metabolism in remarkably similar ways, regardless of tissue origin.

How can cancers in completely different organs share such striking similarities?

Because they exploit the same underlying biochemical vulnerabilities in cellular function.

Join Dr. Dayan Goodenowe in this exclusive live presentation as we explore:

Register Now:
This Conversation Changes Everything

Dr. Goodenowe presents the latest research on cancer biochemistry that will challenge conventional understanding and provide cutting-edge scientific insights into cellular function, metabolic health, and resilience.

Tuesday, November 19th, 2025 • 4:00 PM Pacific

INTRODUCING OUR SPEAKER

Dr. Dayan Goodenowe

World-Renowned Neuroscientist & Bestselling Author

 

Dr. Dayan Goodenowe is a world-renowned neuroscientist whose research into the biochemical mechanisms of disease started in 1990. His curiosity about the biochemistry of life remains as insatiable today as it was over three decades ago.

 

Dr. Goodenowe invented and developed advanced diagnostic and bioinformatic technologies, designed and manufactured novel biochemical precursors, and identified biochemical prodromes of numerous diseases including Alzheimer’s disease and dementia, Parkinson’s disease, multiple sclerosis, stroke, autism, amyotrophic lateral sclerosis (ALS), schizophrenia, bipolar disorder, depression, and multiple types of cancer.

 

As the founder of Prodrome Sciences and author of the bestselling book “Breaking Alzheimer’s,” Dr. Goodenowe’s research focuses on identifying and correcting the biochemical imbalances that affect cellular function—long before disease becomes irreversible.

 

His current focus is to defeat the entropy of aging by creating strategic biochemical and biofunctional reserve capacity in advance of known disease risks, enabling the human body to maintain optimal physical and biological functions.

As the founder of Prodrome Science and author of the bestselling book "Breaking Alzheimer's," Dr. Goodenowe's research focuses on identifying and correcting the biochemical imbalances that affect brain function—long before symptoms become irreversible.


His current focus is to defeat the entropy of aging by creating strategic biochemical and biofunctional reserve capacity in advance of known disease risks, enabling the human body to maintain optimal physical and biological functions.


View More

A New Approach to Understanding Cancer

This presentation offers evidence-based, scientifically-grounded understanding of cancer that explores the biochemical foundations of cellular health, stress response, and resilience.

What You'll Discover:

Live Webinar Details

Exclusive for Live Attendees

:gift: Live-Attendee Giveaway!Join us live for a chance to win a complimentary ProdromeScan with a personal interpretation by Dr. Dayan Goodenowe! One lucky winner will be notified by email. For research and educational purposes only. Not for diagnostic use. (US RESIDENTS ONLY)

IT'S GOING TO BE A LECTURE YOU WON'T WANT TO MISS

Why Attend This Event?

Don't Miss This Groundbreaking Presentation

Whether you have personal experience with cancer, are caring for someone with the condition, or want to understand this disease at a deeper level, this presentation provides direct scientific insights backed by decades of biochemical research.

GROUNDBREAKING RESEARCH REVEALED

What People Are Saying About Dr. Goodenowe's Work

The Science of Understanding Starts Here

  • Join hundreds discovering new pathways for understanding cancer at the most fundamental level: the biochemical mechanisms that govern every cell in your body.

Tuesday, November 19th, 2025 • 4:00 PM Pacific

This webinar is presented by Perpetual Health in partnership with Prodrome Sciences. Dr. Goodenowe’s research-based insights are grounded in peer-reviewed science and decades of biochemical research.

 

This presentation is for educational purposes only and not intended as medical advice. Cancer is a complex disease requiring medical supervision. Always consult with qualified healthcare professionals regarding any health concerns or treatment decisions.